The Microtome Market size was estimated at USD 428.0 Million in 2022 and is expected to reach USD 724.4 Million by 2030 with a growing CAGR of 6.8% over the forecast period of 2023 to 2030.
It is primarily driven by the increased prevalence of chronic illnesses, an ageing population, and rising healthcare costs, particularly in industrialised nations. One of the primary elements expected to enhance development is the increasing commercial availability of high-quality diagnostic technology in developed nations, which accounts for the majority of revenue. Nonetheless, there remains an unmet need for technologically advanced diagnostic equipment in poor countries due to lower per capita disposable income and limited commercial availability. A microtome is an instrument used to cut tiny slices from plant or animal tissue samples. Depending on the type of specimen and the necessary thickness, the tool employs unique blades made of metal, glass, or diamond.
.png)
To Get More Information on Microtome Market - Request Sample Report
The market is being driven by increased knowledge about the early detection of different chronic illnesses as well as the advent of technologically enhanced diagnostic equipment and pathology systems. Furthermore, an increase in the prevalence of chronic diseases such as cancer, along with an increase in the elderly population, drives market expansion. However, an unfavourable reimbursement condition limits market expansion.
DRIVERS
Chronic disease prevalence is increasing, technological advancements
The rising prevalence of chronic illnesses like cancer and cardiovascular disease raises the demand for histopathology tests. Microtomes are important in preparing tissue samples for precise diagnosis, which contributes to market growth. Continuous improvements in microtome technology, such as automated and digital microtomes, increase tissue sectioning precision, efficiency, and convenience of use. These technical advancements boost acceptance and market expansion.
RESTRAIN
The high expense of sophisticated microtomes as well as the availability of alternative approaches.
OPPORTUNITY
Emerging markets, digital pathology integration.
Growing healthcare infrastructure and increased investment in medical facilities in emerging nations provide considerable market expansion potential. These areas frequently have a growing demand for histopathology, which might encourage the use of microtomes. Microtomes integrated with digital pathology systems allow for quick image interpretation, remote consultation, and data administration. As digital pathology becomes more popular, microtome manufacturers will have more opportunity to combine their technologies and provide full solutions.
CHALLENGES
Lack of skilled professionals
Reimbursement challenges
Reduced healthcare spending Conflicts can put national economies under strain, diverting funding away from healthcare budgets. Reduced healthcare funding may hinder the purchase of new medical equipment, such as microtomes. Laboratories may prioritise expenditure on key equipment and supplies while deferring or cutting back on non-essential equipment improvements.
During times of conflict and insecurity, research emphasis may shift towards solving acute health concerns and emergency care. Basic research and non-essential diagnoses, such as histopathology studies using microtomes, may be given less attention and money. Uncertainty in the market in conflict's geopolitical instability may cause customers, notably healthcare institutions and laboratories, to be wary. Uncertainty about the future and prospective geopolitical changes might cause investors to be hesitant to make long-term investments, thereby affecting the microtome industry.
IMPACT OF ONGOING RECESSION
Price competition Healthcare organisations and institutions may become more price-sensitive during an economic crisis. They may seek cost reductions and negotiate pricing with vendors, including microtome makers. Manufacturers may be under additional pressure to provide competitive prices or discounts in order to retain customers and obtain new orders. Market concentration and consolidation Economic downturns can cause industry consolidation as businesses attempt to cut costs and enhance efficiency. This may result in mergers, acquisitions, or closures of smaller producers or distributors in the microtome business, resulting in market concentration among bigger competitors. During a recession, healthcare organisations may prioritise spending on vital medical equipment and supplies while decreasing spending on non-essential goods.
By Product
Microtome Devices
Rotary Microtome
Vibrating Microtome
Other Microtome
Accessories
By Technology
Fully Automated
Semiautomated
Manual
.png)
Do You Need any Customization Research on Microtome Market - Enquire Now
North America
US
Canada
Mexico
Europe
Eastern Europe
Poland
Romania
Hungary
Turkey
Rest of Eastern Europe
Western Europe
Germany
France
UK
Italy
Spain
Netherlands
Switzerland
Austria
Rest of Western Europe
Asia Pacific
China
India
Japan
South Korea
Vietnam
Singapore
Australia
Rest of Asia Pacific
Middle East & Africa
Middle East
UAE
Egypt
Saudi Arabia
Qatar
Rest of Middle East
Africa
Nigeria
South Africa
Rest of Africa
Latin America
Brazil
Argentina
Colombia
Rest of Latin America
REGIONAL ANALYSES
North America held the biggest market share of 50.1% due to improved healthcare infrastructure, increased public and private sector expenditures in in vitro diagnostics, the existence of a large number of market participants, and the adoption of technologically sophisticated products. Furthermore, the rising frequency of cancer in North America is increasing demand for biopsies, resulting in increased demand.
Over the next several years, Asia-Pacific is predicted to be the fastest-growing area. This region is expected to increase dramatically as per capita income rises, the medical tourism business expands, and public awareness of the benefits of early detection grows. In comparison to Japan, China is expected to expand quicker in the Asia-Pacific area.
The major players are LLS ROWIAK LaserLabSolutions GmbH, Leica Biosystems Nussloch GmbH, Sakura, MEDITE GmbH, SLEE medical GmbH, Boeckeler Instruments, Nanolytik, S.M. Scientific Instruments Pvt. Ltd, MICROS Austria Produktions-und Handelsges.m.b.H, AGD Biomedicals (P) Ltd,.and others
Myriad Genetics: In June 2023, Myriad Genetics, Inc., a genetic testing and precision medicine firm located in Salt Lake City, Utah, unveiled new research and expanded its Precise Oncology Solutions portfolio at the American Society of Clinical Oncology (ASCO) in 2023.
F. Hoffmann-La Roche Ltd: In March 2023, F. Hoffmann-La Roche Ltd (Roche), a biotechnology company that develops drugs and vaccines and diagnostics for serious illnesses, announced a cooperation with Eli Lilly and Company, a pharmaceutical business located in the United States, to boost the development of Roche's Elecsys Microtomes.
| Report Attributes | Details |
| Market Size in 2022 | US$ 428.0 Mn |
| Market Size by 2030 | US$ 724.4 Mn |
| CAGR | CAGR of 6.8 % From 2023 to 2030 |
| Base Year | 2022 |
| Forecast Period | 2023-2030 |
| Historical Data | 2020-2021 |
| Report Scope & Coverage | Market Size, Segments Analysis, Competitive Landscape, Regional Analysis, DROC & SWOT Analysis, Forecast Outlook |
| Key Segments | • By Product (Microtome Devices, Rotary Microtome, Vibrating Microtome, Other Microtome, Accessories) • By Technology (Fully Automated, Semiautomated, Manual) |
| Regional Analysis/Coverage | North America (US, Canada, Mexico), Europe (Eastern Europe [Poland, Romania, Hungary, Turkey, Rest of Eastern Europe] Western Europe] Germany, France, UK, Italy, Spain, Netherlands, Switzerland, Austria, Rest of Western Europe]). Asia Pacific (China, India, Japan, South Korea, Vietnam, Singapore, Australia, Rest of Asia Pacific), Middle East & Africa (Middle East [UAE, Egypt, Saudi Arabia, Qatar, Rest of Middle East], Africa [Nigeria, South Africa, Rest of Africa], Latin America (Brazil, Argentina, Colombia Rest of Latin America) |
| Company Profiles | LLS ROWIAK LaserLabSolutions GmbH; Leica Biosystems Nussloch GmbH; Sakura; MEDITE GmbH; SLEE medical GmbH; Boeckeler Instruments; Nanolytik; S.M. Scientific Instruments Pvt. Ltd.; MICROS Austria Produktions-und Handelsges.m.b.H; AGD Biomedicals (P) Ltd |
| Key Drivers | • Chronic disease prevalence is increasing, technological advancements |
| Market Restraints | • The high expense of sophisticated microtomes as well as the availability of alternative approaches. |
Ans: Microtome Market is anticipated to expand by 6.8% from 2023 to 2030.
Ans: USD 724.4 Million is expected to grow by 2030.
Ans: Microtome Market size was valued at USD 428.0 Million in 2022
Ans: North America is dominating the market.
Ans: Lack of skilled professionals and Reimbursement challenges
TABLE OF CONTENTS
1. Introduction
1.1 Market Definition
1.2 Scope
1.3 Research Assumptions
2. Research Methodology
3. Market Dynamics
3.1 Drivers
3.2 Restraints
3.3 Opportunities
3.4 Challenges
4. Impact Analysis
4.1 Impact of the Russia-Ukraine War
4.2 Impact of Ongoing Recession
4.2.1 Introduction
4.2.2 Impact on major economies
4.2.2.1 US
4.2.2.2 Canada
4.2.2.3 Germany
4.2.2.4 France
4.2.2.5 United Kingdom
4.2.2.6 China
4.2.2.7 Japan
4.2.2.8 South Korea
4.2.2.9 Rest of the World
5. Value Chain Analysis
6. Porter’s 5 forces model
7. PEST Analysis
8. Microtome Market Segmentation, By Product
8.1 Microtome Devices
8.2 Rotary Microtome
8.3 Vibrating Microtome
8.4 Other Microtome
8.5 Accessories
9. Microtome Market Segmentation, By Technology
9.1 Fully Automated
9.2 Semiautomated
9.3 Manual
10. Regional Analysis
10.1 Introduction
10.2 North America
10.2.1 North America Microtome Market by Country
10.2.2North America Microtome Market by Product
10.2.3 North America Microtome Market by Technology
10.2.4 USA
10.2.4.1 USA Microtome Market by Product
10.2.4.2 USA Microtome Market by Technology
10.2.5 Canada
10.2.5.1 Canada Microtome Market by Product
10.2.5.2 Canada Microtome Market by Technology
10.2.6 Mexico
10.2.6.1 Mexico Microtome Market by Product
10.2.6.2 Mexico Microtome Market by Technology
10.3 Europe
10.3.1 Eastern Europe
10.3.1.1 Eastern Europe Microtome Market by Country
10.3.1.2 Eastern Europe Microtome Market by Product
10.3.1.3 Eastern Europe Microtome Market by Technology
10.3.1.4 Poland
10.3.1.4.1 Poland Microtome Market by Product
10.3.1.4.2 Poland Microtome Market by Technology
10.3.1.5 Romania
10.3.1.5.1 Romania Microtome Market by Product
10.3.1.5.2 Romania Microtome Market by Technology
10.3.1.6 Hungary
10.3.1.6.1 Hungary Microtome Market by Product
10.3.1.6.2 Hungary Microtome Market by Technology
10.3.1.7 Turkey
10.3.1.7.1 Turkey Microtome Market by Product
10.3.1.7.2 Turkey Microtome Market by Technology
10.3.1.8 Rest of Eastern Europe
10.3.1.8.1 Rest of Eastern Europe Microtome Market by Product
10.3.1.8.2 Rest of Eastern Europe Microtome Market by Technology
10.3.2 Western Europe
10.3.2.1 Western Europe Microtome Market by Country
10.3.2.2 Western Europe Microtome Market by Product
10.3.2.3 Western Europe Microtome Market by Technology
10.3.2.4 Germany
10.3.2.4.1 Germany Microtome Market by Product
10.3.2.4.2 Germany Microtome Market by Technology
10.3.2.5 France
10.3.2.5.1 France Microtome Market by Product
10.3.2.5.2 France Microtome Market by Technology
10.3.2.6 UK
10.3.2.6.1 UK Microtome Market by Product
10.3.2.6.2 UK Microtome Market by Technology
10.3.2.7 Italy
10.3.2.7.1 Italy Microtome Market by Product
10.3.2.7.2 Italy Microtome Market by Technology
10.3.2.8 Spain
10.3.2.8.1 Spain Microtome Market by Product
10.3.2.8.2 Spain Microtome Market by Technology
10.3.2.9 Netherlands
10.3.2.9.1 Netherlands Microtome Market by Product
10.3.2.9.2 Netherlands Microtome Market by Technology
10.3.2.10 Switzerland
10.3.2.10.1 Switzerland Microtome Market by Product
10.3.2.10.2 Switzerland Microtome Market by Technology
10.3.2.11 Austria
10.3.2.11.1 Austria Microtome Market by Product
10.3.2.11.2 Austria Microtome Market by Technology
10.3.2.12 Rest of Western Europe
10.3.2.12.1 Rest of Western Europe Microtome Market by Product
10.3.2.12.2 Rest of Western Europe Microtome Market by Technology
10.4 Asia-Pacific
10.4.1 Asia Pacific Microtome Market by Country
10.4.2 Asia Pacific Microtome Market by Product
10.4.3 Asia Pacific Microtome Market by Technology
10.4.4 China
10.4.4.1 China Microtome Market by Product
10.4.4.2 China Microtome Market by Technology
10.4.5 India
10.4.5.1 India Microtome Market by Product
10.4.5.2 India Microtome Market by Technology
10.4.6 Japan
10.4.6.1 Japan Microtome Market by Product
10.4.6.2 Japan Microtome Market by Technology
10.4.7 South Korea
10.4.7.1 South Korea Microtome Market by Product
10.4.7.2 South Korea Microtome Market by Technology
10.4.8 Vietnam
10.4.8.1 Vietnam Microtome Market by Product
10.4.8.2 Vietnam Microtome Market by Technology
10.4.9 Singapore
10.4.9.1 Singapore Microtome Market by Product
10.4.9.2 Singapore Microtome Market by Technology
10.4.10 Australia
10.4.10.1 Australia Microtome Market by Product
10.4.10.2 Australia Microtome Market by Technology
10.4.11 Rest of Asia-Pacific
10.4.11.1 Rest of Asia-Pacific Microtome Market by Product
10.4.11.2 Rest of Asia-Pacific Microtome Market by Technology
10.5 Middle East & Africa
10.5.1 Middle East
10.5.1.1 Middle East Microtome Market by Country
10.5.1.2 Middle East Microtome Market by Product
10.5.1.3 Middle East Microtome Market by Technology
10.5.1.4 UAE
10.5.1.4.1 UAE Microtome Market by Product
10.5.1.4.2 UAE Microtome Market by Technology
10.5.1.5 Egypt
10.5.1.5.1 Egypt Microtome Market by Product
10.5.1.5.2 Egypt Microtome Market by Technology
10.5.1.6 Saudi Arabia
10.5.1.6.1 Saudi Arabia Microtome Market by Product
10.5.1.6.2 Saudi Arabia Microtome Market by Technology
10.5.1.7 Qatar
10.5.1.7.1 Qatar Microtome Market by Product
10.5.1.7.2 Qatar Microtome Market by Technology
10.5.1.8 Rest of Middle East
10.5.1.8.1 Rest of Middle East Microtome Market by Product
10.5.1.8.2 Rest of Middle East Microtome Market by Technology
10.5.2 Africa
10.5.2.1 Africa Microtome Market by Country
10.5.2.2 Africa Microtome Market by Product
10.5.2.3 Africa Microtome Market by Technology
10.5.2.4 Nigeria
10.5.2.4.1 Nigeria Microtome Market by Product
10.5.2.4.2 Nigeria Microtome Market by Technology
10.5.2.5 South Africa
10.5.2.5.1 South Africa Microtome Market by Product
10.5.2.5.2 South Africa Microtome Market by Technology
10.5.2.6 Rest of Africa
10.5.2.6.1 Rest of Africa Microtome Market by Product
10.5.2.6.2 Rest of Africa Microtome Market by Technology
10.6 Latin America
10.6.1 Latin America Microtome Market by Country
10.6.2 Latin America Microtome Market by Product
10.6.3 Latin America Microtome Market by Technology
10.6.4 Brazil
10.6.4.1 Brazil Microtome Market by Product
10.6.4.2 Brazil Africa Microtome Market by Technology
10.6.5 Argentina
10.6.5.1 Argentina Microtome Market by Product
10.6.5.2 Argentina Microtome Market by Technology
10.6.6 Colombia
10.6.6.1 Colombia Microtome Market by Product
10.6.6.2 Colombia Microtome Market by Technology
10.6.7 Rest of Latin America
10.6.7.1 Rest of Latin America Microtome Market by Product
10.6.7.2 Rest of Latin America Microtome Market by Technology
11. Company Profile
11.1 LLS ROWIAK LaserLabSolutions GmbH
11.1.1 Company Overview
11.1.2 Financials
11.1.3 Product/Services Offered
11.1.4 SWOT Analysis
11.1.5 The SNS View
11.2 Leica Biosystems Nussloch GmbH
11.2.1 Company Overview
11.2.2 Financials
11.2.3 Product/Services Offered
11.2.4 SWOT Analysis
11.2.5 The SNS View
11.3 Sakura
11.3.1 Company Overview
11.3.2 Financials
11.3.3 Product/Services Offered
11.3.4 SWOT Analysis
11.3.5 The SNS View
11.4 MEDITE GmbH
11.4 Company Overview
11.4.2 Financials
11.4.3 Product/Services Offered
11.4.4 SWOT Analysis
11.4.5 The SNS View
11.5 SLEE Medical GmbH
11.5.1 Company Overview
11.5.2 Financials
11.5.3 Product/Services Offered
11.5.4 SWOT Analysis
11.5.5 The SNS View
11.6 Boeckeler Instruments
11.6.1 Company Overview
11.6.2 Financials
11.6.3 Product/Services Offered
11.6.4 SWOT Analysis
11.6.5 The SNS View
11.7 Nanolytik
11.7.1 Company Overview
11.7.2 Financials
11.7.3 Product/Services Offered
11.7.4 SWOT Analysis
11.7.5 The SNS View
11.8 S.M. Scientific Instruments Pvt. Ltd
11.8.1 Company Overview
11.8.2 Financials
11.8.3 Product/Services Offered
11.8.4 SWOT Analysis
11.8.5 The SNS View
11.9 MICROS Austria Produktions-und Handelsges.m.b.H
11.9.1 Company Overview
11.9.2 Financials
11.9.3 Product/ Services Offered
11.9.4 SWOT Analysis
11.9.5 The SNS View
11.10 AGD Biomedicals (P) Ltd
11.10.1 Company Overview
11.10.2 Financials
11.10.3 Product/Services Offered
11.10.4 SWOT Analysis
11.10.5 The SNS View
12. Competitive Landscape
12.1 Competitive Benchmarking
12.2 Market Share Analysis
12.3 Recent Developments
12.3.1 Industry News
12.3.2 Company News
12.3.3 Mergers & Acquisitions
13. USE Cases and Best Practices
14. Conclusion
An accurate research report requires proper strategizing as well as implementation. There are multiple factors involved in the completion of good and accurate research report and selecting the best methodology to compete the research is the toughest part. Since the research reports we provide play a crucial role in any company’s decision-making process, therefore we at SNS Insider always believe that we should choose the best method which gives us results closer to reality. This allows us to reach at a stage wherein we can provide our clients best and accurate investment to output ratio.
Each report that we prepare takes a timeframe of 350-400 business hours for production. Starting from the selection of titles through a couple of in-depth brain storming session to the final QC process before uploading our titles on our website we dedicate around 350 working hours. The titles are selected based on their current market cap and the foreseen CAGR and growth.
The 5 steps process:
Step 1: Secondary Research:
Secondary Research or Desk Research is as the name suggests is a research process wherein, we collect data through the readily available information. In this process we use various paid and unpaid databases which our team has access to and gather data through the same. This includes examining of listed companies’ annual reports, Journals, SEC filling etc. Apart from this our team has access to various associations across the globe across different industries. Lastly, we have exchange relationships with various university as well as individual libraries.
Step 2: Primary Research
When we talk about primary research, it is a type of study in which the researchers collect relevant data samples directly, rather than relying on previously collected data. This type of research is focused on gaining content specific facts that can be sued to solve specific problems. Since the collected data is fresh and first hand therefore it makes the study more accurate and genuine.
We at SNS Insider have divided Primary Research into 2 parts.
Part 1 wherein we interview the KOLs of major players as well as the upcoming ones across various geographic regions. This allows us to have their view over the market scenario and acts as an important tool to come closer to the accurate market numbers. As many as 45 paid and unpaid primary interviews are taken from both the demand and supply side of the industry to make sure we land at an accurate judgement and analysis of the market.
This step involves the triangulation of data wherein our team analyses the interview transcripts, online survey responses and observation of on filed participants. The below mentioned chart should give a better understanding of the part 1 of the primary interview.
Part 2: In this part of primary research the data collected via secondary research and the part 1 of the primary research is validated with the interviews from individual consultants and subject matter experts.
Consultants are those set of people who have at least 12 years of experience and expertise within the industry whereas Subject Matter Experts are those with at least 15 years of experience behind their back within the same space. The data with the help of two main processes i.e., FGDs (Focused Group Discussions) and IDs (Individual Discussions). This gives us a 3rd party nonbiased primary view of the market scenario making it a more dependable one while collation of the data pointers.
Step 3: Data Bank Validation
Once all the information is collected via primary and secondary sources, we run that information for data validation. At our intelligence centre our research heads track a lot of information related to the market which includes the quarterly reports, the daily stock prices, and other relevant information. Our data bank server gets updated every fortnight and that is how the information which we collected using our primary and secondary information is revalidated in real time.
Step 4: QA/QC Process
After all the data collection and validation our team does a final level of quality check and quality assurance to get rid of any unwanted or undesired mistakes. This might include but not limited to getting rid of the any typos, duplication of numbers or missing of any important information. The people involved in this process include technical content writers, research heads and graphics people. Once this process is completed the title gets uploader on our platform for our clients to read it.
Step 5: Final QC/QA Process:
This is the last process and comes when the client has ordered the study. In this process a final QA/QC is done before the study is emailed to the client. Since we believe in giving our clients a good experience of our research studies, therefore, to make sure that we do not lack at our end in any way humanly possible we do a final round of quality check and then dispatch the study to the client.
The Monoclonal Antibody Therapy Market size was valued at USD 87.8 Bn in 2023 and is expected to reach USD 230.38 Bn by 2031 with a growing CAGR of 12.8% Over the Forecast Period of 2024-2031.
The Life Science Tools Market size was estimated at USD 158.40 billion in 2023 and is expected to reach USD 407.57 billion by 2032 with a growing CAGR of 11.09% during the forecast period of 2024-2032.
The Veterinary Vaccines Market size was valued at USD 8.5 Billion in 2023 and is expected to reach USD 14.5 Billion By 2032 and grow at a CAGR of 6% over the forecast period of 2024-2032.
The Sexual Health Products Market Size was valued at USD 118.83 Billion in 2023, and is expected to reach USD 243.83 Billion by 2032, and grow at a CAGR of 8.71% over the forecast period 2024-2032.
The global Polyclonal Antibodies Market, valued at USD 1.52 Billion in 2023, is projected to reach USD 2.39 Billion by 2032, growing at a compound annual growth rate (CAGR) of 5.36% during the forecast period.
The Electronic Trial Master File (eTMF) Systems Market Size was valued at USD 1.68 billion in 2023, and is expected to reach USD 4.40 billion by 2031 and grow at a CAGR of 12.8% over the forecast period 2024-2031.
Hi! Click one of our member below to chat on Phone
© 2024 All Rights Reserved by SNS Insider Pvt Ltd
